Ms Saheli Roy

Ms Saheli Roy

Present Position: Assistant Professor

Department of Pharmaceutical Technology, School of Medical Sciences



  • PhD (Pharmaceutical Technology).pursuing from (Jadavpur University)
  • M.S.(Pharm) in Pharmaceutical Biotechnology, (National institute of Pharmaceutical education and research)(NIPER-HAJIPUR)
  • B.Pharm, (Gurunanak Institute of Pharmaceutical science and technology)(WBUT)

Research Key Areas:

  • Nanobiotechnology
  • Disease ameliorating role of various natural, synthetic compounds.
  • Cancer biology
  • Pulmonary Inflammatory disorders.


  • Assistant Professor, Adamas University, India, 2021-
  • ICMR-Senior Research Fellow, CSIR-Indian Institute of Chemical Biology(2018-2021)
  • ICMR- Junior Research Fellow, CSIR-Indian Institute of Chemical Biology(2016-2018)
  • Assistant Professor, Bihar college of Pharmacy(2016 Jan-June)

Research Publication (s):

  • Number of research papers published in International refereed journals: 3
  • Number of research papers published in International peer-reviewed Scopus Proceedings: Nil

Selected Publication (s):

    1. Roy S, Manna K, Jha T, Saha KD. Chrysin-loaded PLGA attenuates OVA-induced allergic asthma by modulating TLR/NF-κB/NLRP3 axis. Nanomedicine. 2020 Nov;30:102292. doi: 10.1016/j.nano.2020.102292. Epub 2020 Aug 25. PMID: 32853785.
    2. Chakraborty S, Ehsan I, Mukherjee B, Mondal L, Roy S, Saha KD, Paul B, Debnath MC, Bera T. Therapeutic potential of andrographolide-loaded nanoparticles on a murine asthma model. Nanomedicine. 2019 Aug;20:102006. doi: 10.1016/j.nano.2019.04.009. Epub 2019 May 3. PMID: 31059793.
    3. Banerji B, Chandrasekhar K, Sreenath K, Roy S, Nag S, Saha KD. Synthesis of Triazole-Substituted Quinazoline Hybrids for Anticancer Activity and a Lead Compound as the EGFR Blocker and ROS Inducer Agent. ACS Omega. 2018 Nov 30;3(11):16134-16142. doi: 10.1021/acsomega.8b01960. Epub 2018 Nov 28. PMID: 30556027; PMCID: PMC6288807.
    4. Role effectuated by immunomicroenvironment on prognosis of COVID-19 infected asthmatic patients and the potentialities of repurposing immunomodulatory drugs Saheli Roy, Krishna Das Saha – under revision(ALAS-D-21-00026)